Literature DB >> 17905857

Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review.

G L Jones1, J M Hall, A H Balen, W L Ledger.   

Abstract

The symptoms typically associated with polycystic ovary syndrome (PCOS) such as acne, hirsutism, irregular menses, amenorrhoea, obesity and subfertility are a major source of psychological morbidity and can negatively affect quality of life (QoL). We systematically searched the literature to identify the impact of symptoms and treatments for PCOS on health-related QoL (HRQoL) and to report on the types and psychometric properties of the instruments used. Papers were retrieved by systematically searching four electronic databases and hand searching relevant reference lists and bibliographies. Nineteen papers used a standardized questionnaire to measure health status; of these 12 (63.2%) used generic tools and 8 (42%) used the disease-specific PCOS questionnaire. Although a meta-analysis was not possible, it appears that weight concerns have a particular negative impact upon HRQoL, although the role of body mass index in affecting HRQoL scores is inconclusive from the available evidence. Acne is the area least reported upon in terms of its impact upon HRQoL. With the exception of three studies, most of the research has focused upon adult women with PCOS. Despite the benefits of HRQoL measures in research, few are being used to evaluate the outcomes of treatment for PCOS upon the subjective health status of women with the condition.

Entities:  

Mesh:

Year:  2007        PMID: 17905857     DOI: 10.1093/humupd/dmm030

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  41 in total

Review 1.  Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women.

Authors:  Jing Zhang; Liulin Tang; Linglingli Kong; Taixiang Wu; Liangzhi Xu; Xin Pan; Guan J Liu
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

Review 2.  Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Claire Brutocao; Feras Zaiem; Mouaz Alsawas; Allison S Morrow; M Hassan Murad; Asma Javed
Journal:  Endocrine       Date:  2018-07-31       Impact factor: 3.633

3.  Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study.

Authors:  M Noroozzadeh; F Ramezani Tehrani; S Sedigh Mobarakabadi; M Farahmand; M Rostami Dovom
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

4.  Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study.

Authors:  Manizheh Sayyah-Melli; Mahasti Alizadeh; Nosratollah Pourafkary; Elaheh Ouladsahebmadarek; Mehri Jafari-Shobeiri; Jaleh Abbassi; Maryam Alsadat Kazemi-Shishvan; Kamran Sedaghat
Journal:  J Caring Sci       Date:  2015-09-01

5.  The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study.

Authors:  Gwinnett Ladson; William C Dodson; Stephanie D Sweet; Anthony E Archibong; Allen R Kunselman; Laurence M Demers; Nancy I Williams; Ponjola Coney; Richard S Legro
Journal:  Fertil Steril       Date:  2010-12-30       Impact factor: 7.329

6.  Transition to Self-Management among Adolescents with Polycystic Ovary Syndrome: Parent and Adolescent Perspectives.

Authors:  Cara C Young; Lynn Rew; Maria Monge
Journal:  J Pediatr Nurs       Date:  2019-05-09       Impact factor: 2.145

7.  Sexual function in women with polycystic ovary syndrome.

Authors:  Dale W Stovall; Jessica L Scriver; Anita H Clayton; Christopher D Williams; Lisa M Pastore
Journal:  J Sex Med       Date:  2011-11-14       Impact factor: 3.802

Review 8.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

9.  Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

Authors:  Uche Ezeh; Bulent O Yildiz; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 5.958

10.  46,XY DSD with Female or Ambiguous External Genitalia at Birth due to Androgen Insensitivity Syndrome, 5alpha-Reductase-2 Deficiency, or 17beta-Hydroxysteroid Dehydrogenase Deficiency: A Review of Quality of Life Outcomes.

Authors:  Amy B Wisniewski; Tom Mazur
Journal:  Int J Pediatr Endocrinol       Date:  2009-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.